Mouse macrophage innate immune response to chikungunya virus infection

Virology Journal

Volumn 9, Issue , 2012, Pages

  Kumar, Shiril ^a   Jaffar Bandjee, Marie Christine ^a,b   Giry, Claude ^a   Connen De Kerillis, Léa ^a   Merits, Andres ^c   Gasque, Philippe ^a   Hoarau, Jean Jacques ^a  

^a UNIVERSITÉ DE LA RÉUNION   (France)

^b Microbiology/Virology Laboratory   (France)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

Apoptosis; Chikungunya virus; Inflammation; Macrophage; Viral persistence

Indexed keywords

ALPHA INTERFERON; CASPASE 3; CASPASE 9; CYTOKINE RECEPTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5;

ANIMAL CELL; APOPTOSIS; ARTICLE; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; CONTROLLED STUDY; IMMUNE RESPONSE; INFECTION RESISTANCE; INNATE IMMUNITY; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; APOPTOSIS; CELL LINE; CHIKUNGUNYA VIRUS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; IMMUNITY, INNATE; MACROPHAGES; MICE; REAL-TIME POLYMERASE CHAIN REACTION;

CHIKUNGUNYA VIRUS;

EID: 84871163736     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-9-313     Document Type: Article

References (30)

1. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53; an additional note on Chikungunya virus isolations and serum antibodies. Mason PJ, Haddow AJ, Trans R Soc Trop Med Hyg 1957 51 238 240 10.1016/0035-9203(57)90022-6 13443013
2. Proposed antigenic classification of registered arboviruses I. Togaviridae, Alphavirus. Calisher CH, Shope RE, Brandt W, Casals J, Karabatsos N, Murphy FA, Tesh RB, Wiebe ME, Intervirology 1980 14 229 232 10.1159/000149190 6265396 (Pubitemid 11111333)
3. Arthritides caused by mosquito-borne viruses. Tesh RB, Annu Rev Med 1982 33 31 40 10.1146/annurev.me.33.020182.000335 6123291
4. An outbreak of human Semliki Forest virus infections in Central African Republic. Mathiot CC, Grimaud G, Garry P, Bouquety JC, Mada A, Daguisy AM, Georges AJ, Am J Trop Med Hyg 1990 42 386 393 2158754 (Pubitemid 20137313)
5. Chikungunya virus takes centre stage in virally induced arthritis: possible cellular and molecular mechanisms to pathogenesis. Jaffar-Bandjee MC, Das T, Hoarau JJ, Krejbich Trotot P, Denizot M, Ribera A, Roques P, Gasque P, Microbes and infection / Institut Pasteur 2009 11 1206 1218 10.1016/j.micinf. 2009.10.001 19835977
6. Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses. Suhrbier A, La Linn M, Curr Opin Rheumatol 2004 16 374 379 10.1097/01.bor.0000130537.76808.26 15201600 (Pubitemid 38803138)
7. Viral evasion and subversion of pattern-recognition receptor signalling. Bowie AG, Unterholzner L, Nat Rev Immunol 2008 8 911 922 10.1038/nri2436 18989317
8. RNA recognition and signal transduction by RIG-I-like receptors. Yoneyama M, Fujita T, Immunol Rev 2009 227 54 65 10.1111/j.1600-065X.2008.00727.x 19120475
9. Regulators of apoptosis on the road to persistent alphavirus infection. Griffin DE, Hardwick JM, Annu Rev Microbiol 1997 51 565 592 10.1146/annurev. micro.51.1.565 9343360 (Pubitemid 27433059)
10. Programmed cell death in the immune system. Cohen JJ, Adv Immunol 1991 50 55 85 1950799
11. Apoptosis: a basic physiologic process in wound healing. Rai NK, Tripathi K, Sharma D, Shukla VK, Int J Low Extrem Wounds 2005 4 138 144 10.1177/1534734605280018 16100094 (Pubitemid 41437580)
12. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, Denizot M, Guichard E, Ribera A, Henni T, J Immunol 2010 184 5914 5927 10.4049/jimmunol. 0900255 20404278
13. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, Guigand L, Dubreil L, Lebon P, Verrier B, J Clin Invest 2010 120 894 906 10.1172/JCI40104 20179353
14. Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response. Her Z, Malleret B, Chan M, Ong EK, Wong SC, Kwek DJ, Tolou H, Lin RT, Tambyah PA, Renia L, Ng LF, J Immunol 2010 184 5903 5913 10.4049/jimmunol.0904181 20404274
15. Characterization of reemerging chikungunya virus. Sourisseau M, Schilte C, Casartelli N, Trouillet C, Guivel-Benhassine F, Rudnicka D, Sol-Foulon N, Le Roux K, Prevost MC, Fsihi H, PLoS Pathog 2007 3 89 10.1371/journal.ppat.0030089 17604450 (Pubitemid 47015880)
16. Chikungunya virus arthritis in adult wild-type mice. Gardner J, Anraku I, Le TT, Larcher T, Major L, Roques P, Schroder WA, Higgs S, Suhrbier A, J Virol 2010 84 8021 8032 10.1128/JVI.02603-09 20519386
17. Development of a TaqMan RT-PCR assay without RNA extraction step for the detection and quantification of African Chikungunya viruses. Pastorino B, Bessaud M, Grandadam M, Murri S, Tolou HJ, Peyrefitte CN, J Virol Methods 2005 124 65 71 10.1016/j.jviromet.2004.11.002 15664052 (Pubitemid 40142652)
18. Chikungunya fever: CNS infection and pathologies of a re-emerging arbovirus. Das T, Jaffar-Bandjee MC, Hoarau JJ, Krejbich Trotot P, Denizot M, Lee-Pat-Yuen G, Sahoo R, Guiraud P, Ramful D, Robin S, Prog Neurobiol 2009
19. Measles virus-induced suppression of immune responses. Griffin DE, Immunol Rev 2010 236 176 189 10.1111/j.1600-065X.2010.00925.x 20636817
20. Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage. Le Douce V, Herbein G, Rohr O, Schwartz C, Retrovirology 2010 7 32 10.1186/1742-4690-7-32 20380694
21. Chikungunya virus mobilizes the apoptotic machinery to invade host cell defenses. Krejbich-Trotot P, Denizot M, Hoarau JJ, Jaffar-Bandjee MC, Das T, Gasque P, The FASEB J 2011 25 314 325 10.1096/fj.10-164178
22. A blast from the past: clearance of apoptotic cells regulates immune responses. Savill J, Dransfield I, Gregory C, Haslett C, Nat Rev Immunol 2002 2 965 975 10.1038/nri957 12461569 (Pubitemid 37323217)
23. Regulation of I kappa B alpha and p105 in monocytes and macrophages persistently infected with human immunodeficiency virus. McElhinny JA, MacMorran WS, Bren GD, Ten RM, Israel A, Paya CV, J Virol 1995 69 1500 1509 7853483
24. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM, Nature 1993 361 739 742 10.1038/361739a0 8441470 (Pubitemid 23070484)
25. Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. Ryman KD, Klimstra WB, Nguyen KB, Biron CA, Johnston RE, J Virol 2000 74 3366 3378 10.1128/JVI.74.7.3366-3378.2000 10708454 (Pubitemid 30143762)
26. Up-regulation of interferon-stimulated gene15 and its conjugates by tumor necrosis factor-alpha via type I interferon-dependent and -independent pathways. Chairatvit K, Wongnoppavich A, Choonate S, Mol Cell Biochem 2012 368 195 201 10.1007/s11010-012-1360-5 22729740
27. Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling. Fros JJ, Liu WJ, Prow NA, Geertsema C, Ligtenberg M, Vanlandingham DL, Schnettler E, Vlak JM, Suhrbier A, Khromykh AA, Pijlman GP, J Virol 2010 84 10877 10887 10.1128/JVI.00949-10 20686047
28. Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM, Science 1996 274 787 789 10.1126/science.274.5288.787 8864120 (Pubitemid 26398260)
29. Identification and characterization of a ross river virus variant that grows persistently in macrophages, shows altered disease kinetics in a mouse model, and exhibits resistance to type I interferon. Lidbury BA, Rulli NE, Musso CM, Cossetto SB, Zaid A, Suhrbier A, Rothenfluh HS, Rolph MS, Mahalingam S, J Virol 2011 85 5651 5663 10.1128/JVI.01189-10 21430046
30. Emergence and clinical insights into the pathology of Chikungunya virus infection. Jaffar-Bandjee MC, Ramful D, Gauzere BA, Hoarau JJ, Krejbich-Trotot P, Robin S, Ribera A, Selambarom J, Gasque P, Expert Rev Anti Infect Ther 2010 8 987 996 10.1586/eri.10.92 20818943